News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Yeramian Patrick D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2023 |
4
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 11,965 shares
@ $29.0312, valued at
$347.4k
Exercised 2,201 options to buy
@ $0.37, valued at
$814.4
Exercised 9,764 options to buy
@ $6.88, valued at
$67.2k
|
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/24/2023 |
4/A
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 52,211 shares
@ $31.8485, valued at
$1.7M
Sold 2,416 shares
@ $32.4331, valued at
$78.4k
Granted 9,167 shares
@ $0
Granted 41,250 options to buy
@ $32.08, valued at
$1.3M
Exercised 2,789 options to buy
@ $0.33, valued at
$920.4
Exercised 30,041 options to buy
@ $0.37, valued at
$11.1k
Exercised 16,748 options to buy
@ $6.88, valued at
$115.2k
|
|
| 03/20/2023 |
4
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 52,211 shares
@ $31.8485, valued at
$1.7M
Sold 2,416 shares
@ $32.4331, valued at
$78.4k
Granted 9,167 shares
@ $0
Granted 41,250 options to buy
@ $32.08, valued at
$1.3M
|
|
| 03/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/10/2023 |
4
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 1,405 shares
@ $36.0789, valued at
$50.7k
Sold 629 shares
@ $36.7888, valued at
$23.1k
|
|
| 01/10/2022 |
4
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 28,333 shares
@ $0
Granted 127,500 options to buy
@ $19, valued at
$2.4M
|
|
| 01/06/2022 |
3
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 3 on Amylyx Pharmaceuticals, Inc. |
| 10/28/2020 |
5
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 5 on BIOVIE INC. |
| 03/13/2019 |
3
| Yeramian Patrick D (Chief Medical Officer) has filed a Form 3 on BIOVIE INC. |
|
|